Human cytomegalovirus terminase inhibitors letermovir, tomeglovir, and the halogenated benzimidazoles modify DNA cleavage/packaging to generate a super-genomic DNA species by cleavage site skipping

Authors:

Abstract
No abstract available
Funding Information
  • Ministry of Science, ICT and Future Planning
  • Merck Sharp and Dohme K.K.
  • MSD Sharp and Dohme (53560)
  • School of Medicine, Virginia Commonwealth University
  • National Cancer Institute

This publication has 25 references indexed in Scilit: